INVO Fertility, Inc. (IVF) P/E Ratio History
Historical price-to-earnings valuation from 2010 to 2010
Loading P/E history...
IVF Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, INVO Fertility, Inc. (IVF) trades at a price-to-earnings ratio of -0.0x, with a stock price of $1.82 and trailing twelve-month earnings per share of $-20.36.
The current P/E is 100% below its 5-year average of 18215.0x. Over the past five years, IVF's P/E has ranged from a low of 15839.1x to a high of 20590.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, IVF trades at a 100% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, IVF trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our IVF DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
IVF P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 29.5 | 4.40 | +14% | |
| $882M | 9.7Lowest | 0.98Best | -36% | |
| $17B | 30.5 | - | -25% | |
| $21B | 24.7 | - | +18%Best | |
| $21B | 21.8 | - | +14% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
IVF Historical P/E Data (2010–2010)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2010 Q4 | Fri Dec 31 2010 00:00:00 GM | $12288.00 | $0.78 | 15839.1x | -13% |
| FY2010 Q3 | $15974.40 | $0.78 | 20590.9x | +13% |
Average P/E for displayed period: 18215.0x
See IVF's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IVF Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IVF vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIVF — Frequently Asked Questions
Quick answers to the most common questions about buying IVF stock.
Is IVF stock overvalued or undervalued?
IVF current P/E: -0.0x. 5-year average P/E: 18215.0x. Percentile: N/A.
How does IVF's valuation compare to peers?
INVO Fertility, Inc. P/E of -0.0x compares to sector median of 22.3x. Sector comparison provides relative valuation context.
What is IVF's PEG ratio?
IVF PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2010-2010.